Deamino Arginine Vasopressin
"Deamino Arginine Vasopressin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR.
| Descriptor ID |
D003894
|
| MeSH Number(s) |
D06.472.699.631.692.781.100.250 D12.644.400.900.100.250 D12.644.456.925.100.250 D12.644.548.691.692.781.100.250 D12.776.631.650.937.100.250
|
| Concept/Terms |
Deamino Arginine Vasopressin- Deamino Arginine Vasopressin
- Arginine Vasopressin, Deamino
- 1-Desamino-8-arginine Vasopressin
- Vasopressin, 1-Desamino-8-arginine
- Desmopressin
- Vasopressin, Deamino Arginine
- 1-Deamino-8-D-arginine Vasopressin
- Vasopressin, 1-Deamino-8-D-arginine
DDAVP- DDAVP
- Octostim
- Desmotabs
- Octim
- Desmopressine Ferring
- Ferring, Desmopressine
- Desmospray
Desmopressin Acetate- Desmopressin Acetate
- Acetate, Desmopressin
- Desmopressin Monoacetate, Trihydrate
- Monoacetate, Trihydrate Desmopressin
- Trihydrate Desmopressin Monoacetate
|
Below are MeSH descriptors whose meaning is more general than "Deamino Arginine Vasopressin".
Below are MeSH descriptors whose meaning is more specific than "Deamino Arginine Vasopressin".
This graph shows the total number of publications written about "Deamino Arginine Vasopressin" by people in this website by year, and whether "Deamino Arginine Vasopressin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Deamino Arginine Vasopressin" by people in Profiles.
-
Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer. Cancer Res Treat. 2019 Apr; 51(2):438-450.
-
Differences in bleeding phenotype and provider interventions in postmenarchal adolescents when compared to adult women with bleeding disorders and heavy menstrual bleeding. Haemophilia. 2018 Jan; 24(1):63-69.
-
Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models. Clin Exp Metastasis. 2016 08; 33(6):589-600.
-
Insight into the effect of the vasopressin analog desmopressin on lung colonization by mammary carcinoma cells in BALB/c mice. Anticancer Res. 2014 Sep; 34(9):4761-5.
-
Post-operative diabetes insipidus after endoscopic transsphenoidal surgery. Pituitary. 2013 Dec; 16(4):445-51.
-
Platelet function defects in adolescents with heavy menstrual bleeding. Haemophilia. 2014 Mar; 20(2):249-54.
-
Differential local spasticity in myocardial bridges. Tex Heart Inst J. 2012; 39(3):384-8.
-
Combination therapy with desmopressin and an anticholinergic medication for nonresponders to desmopressin for monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial. Pediatrics. 2008 Nov; 122(5):1027-32.
-
Worsening of thrombotic thromboctyopenic purpura symptoms associated with desmopressin administration. Thromb Haemost. 2004 Oct; 92(4):886-7.
-
Desmopressin inhibits lung and lymph node metastasis in a mouse mammary carcinoma model of surgical manipulation. J Surg Oncol. 2002 Sep; 81(1):38-44.